Danxi Geng
Impact in
-
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
-
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
-
- Blood Pressure and Hypertension Studies 9
- Cardiovascular Function and Risk Factors 1
- Atrial Fibrillation Management and Outcomes 1
-
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Yingxian Sun (8 shared papers)Naijin Zhang (6 shared papers)Yuanming Zou (6 shared papers)Guozhe Sun (8 shared papers)Ying Zhang (2 shared papers)Liu Cao (1 shared paper)Jingwei Liu (1 shared paper)Xinxin Lu (1 shared paper)
- Journals
- BioMed Research International (2 papers)Journal of Advanced Research (2 papers)The Lancet (2 papers)Cell Research (1 paper)Journal of the American Heart Association (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Danxi Geng
17 papers receiving 566 citations
Danxi Geng's Hit Papers
Peers
Comparison fields: 5 of 72
- Cardiology and Cardiovascular Medicine 141
- Cancer Research 84
- Geriatrics and Gerontology 11
- Molecular Biology 181
- Clinical Biochemistry 14
Countries citing papers authored by Danxi Geng
This map shows the geographic impact of Danxi Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danxi Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danxi Geng more than expected).
Fields of papers citing papers by Danxi Geng
This network shows the impact of papers produced by Danxi Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danxi Geng. The network helps show where Danxi Geng may publish in the future.
Co-authors
The 25 scholars most cited alongside Danxi Geng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure Hit paper breakdown → | 2023 | 208 |
| 2 | Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial Hit paper breakdown → | 2023 | 101 |
| 3 | 2023 | 63 | |
| 4 | 2023 | 53 | |
| 5 | 2024 | 40 | |
| 6 | 2020 | 28 | |
| 7 | 2022 | 25 | |
| 8 | 2024 | 17 | |
| 9 | 2025 | 12 | |
| 10 | 2024 | 11 | |
| 11 | 2024 | 9 | |
| 12 | 2023 | 6 | |
| 13 | 2024 | 2 | |
| 14 | 2025 | 2 | |
| 15 | 2022 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 |
About Danxi Geng
Danxi Geng is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research, Molecular Biology, Epidemiology and Computational Theory and Mathematics, having authored 19 papers that have together received 580 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (9 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cardiovascular Function and Risk Factors (1 paper), interferon and immune responses (1 paper), Adipose Tissue and Metabolism (1 paper), Enzyme function and inhibition (1 paper), Cell death mechanisms and regulation (1 paper) and Atrial Fibrillation Management and Outcomes (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (141 citations), Cancer Research (84 citations), Geriatrics and Gerontology (11 citations), Molecular Biology (181 citations) and Clinical Biochemistry (14 citations). Danxi Geng has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Yingxian Sun, Naijin Zhang, Yuanming Zou, Guozhe Sun, Ying Zhang, Liu Cao, Jingwei Liu, Xinxin Lu, Mohan Li and Mengke Liu. Their work appears in journals such as BioMed Research International, Journal of Advanced Research, The Lancet, Cell Research and Journal of the American Heart Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.